ESPN says Gio Gonzalez is clean; Detwiler to World Baseball Classic

ESPN says Washington Nationals pitcher Gio Gonzalez did not obtain banned performance enhancing drugs from the South Florida Biogensis Clinic Sources: Docs link 5 players to clinic:

According to two sources familiar with Bosch’s operation, however, the Washington Nationals’ Gio Gonzalez, previously identified as being named in Biogenesis documents, did not receive banned substances from Bosch or the clinic.

Both sources, speaking independently, identified Gonzalez as the only Bosch client named thus far who did not receive performance-enhancing drugs. A document obtained by “Outside the Lines” bolsters their case: On a computer printout of clients, Gonzalez, identified by the code name “Gladiator,” is said to have received $1,000 worth of substances, but under “notes” are several substances not banned by Major League Baseball: “gluthetyn” (which a source said was a misspelling of glutathione), “IM [intramuscular] shots” and amino acids.

Glutathione is an anti-oxidant, and one source said the “IM shots” Gonzalez received were “MICs,” a medically dubious but legal combination of methionine, inositol and choline, often used for weight loss.

So, that’s good. I still wish he wasn’t pitching in the World Baseball Classic. I am not pleased that Ross Detwiler has joined him – 40% of the rotation is potentially pitching in it now. I’d rather they work up their intensity the traditional way. Throw in Danny Espinosa and his torn rotator cuff in his non-throwing shoulder and welp…

World Baseball Classic now a prime concern for Nationals The Wash. Times

Between the WBC and Bryce Harper on the cover of Sports Illustrated, the spring is nothing but doom for the Nats. Harper has bulked up in the offseason (The Post)

40 days until Opening Day…

Digg This
Reddit This
Stumble Now!
Buzz This
Vote on DZone
Share on Facebook
Bookmark this on Delicious
Kick It on DotNetKicks.com
Shout it
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Leave a Reply